Living donor liver transplantation for patients with HCC exceeding the Milan criteria: A proposal of expanded criteria

Digestive Diseases

Volumn 25, Issue 4, 2007, Pages 299-302

  Takada, Yasutsugu ^a   Ito, Takashi ^a   Ueda, Mikiko ^a   Sakamoto, Seisuke ^a   Haga, Hironori ^a   Maetani, Yoji ^a   Ogawa, Kohei ^a   Ogura, Yasuhiro ^a   Oike, Fumitaka ^a   Egawa, Hiroto ^a   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Living donor liver transplantation; Recurrence; Selection criteria

Indexed keywords

ADULT; AGED; CANCER RECURRENCE; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DONOR SELECTION; FEMALE; HUMAN; IMAGING; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 35548953823     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106908     Document Type: Conference Paper

References (12)

1. Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
2. Jonas S, Bechstein WO, Steinmuller T, et al: Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-1086.
3. Todo S, Furukawa H, on behalf of the Japanese Study Group on Organ Transplantation: Living donor liver transplantation for adult patients with hepatocellular carcinoma. Experience in Japan. Ann Surg 2004;240:451-461.
4. Malago M, Sotiropoulos GC, Nadalin S, et al: Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl 2006;12:934-940.
5. Herrero JI, Sangro B, Quiroga J, et al: Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001;7:631-636.
6. Roayaie S, Frischer J, Emre H, et al: Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 cm. Ann Surg 2002;235:533-539.
7. Yao FY, Ferrell L, Bass NM, et al: Liver transplantation for hepatocellular carcinoma: expansion of tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
8. Gondolesi GE, Roayaie S, Munoz L, et al: Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004;239:142-149.
9. Takada Y, Ueda M, Ito T, et al: Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl 2006;12:912-919.
10. Makuuchi M, Belghiti J, Belli G, et al: IHPBA concordant classification of primary liver cancer: working group report. J Hepatobiliary Pancreatic Surg 2003;10:26-30.
11. Kudo M, Chung H, Haji S, et al: Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 2004;40:1396-1405.
12. Kim YK, Kim CS, Chung GH, et al: Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. Am J Roentgenol 2006;186:149-157.